You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Policy & Regulation
Calidi Biotherapeutics Names Heehyoung Lee to Board of Directors
Login
Username:

Password:


Related Headlines

Merck partners with Isomorphic Labs on AI-driven oncology drug discovery

Dicot Pharma secures EU approval to advance LIB-01 phase 2b study

NFL Biosciences enrolls first participant in Phase 2 smoking cessation trial

Sanofi secures US approval for first treatment targeting neurological symptoms of Type 3 Gaucher disease

Anixa Biosciences and Curia to finalise formulation of breast cancer vaccine for Phase 2 trial

Akagera Medicines receives Gates Foundation grant expansion to advance tuberculosis vaccine

Ten63 Therapeutics launches BEYOND-Alpha early adopter programme

Eloxx Pharmaceuticals publishes Phase 2a exaluren data in nonsense mutation Alport syndrome

Bristol Myers Squibb reports first Phase 3 data for KarXT in Alzheimer's-related psychosis

Pfizer signs licensing agreement with Starna Therapeutics worth up to USD2.63bn

DDL introduces Pharmaceutical Consulting Services for drug delivery support and combination product development

Inhibrx updates clinical data for ozekibart (INBRX-109) in Ewing sarcoma

Dicot Pharma initiates phase 2b clinical study of erectile dysfunction drug candidate

Sobi's Tryngolza for severe hypertriglyceridaemia receives EU approval

Oncoinvent reports favourable interim safety results for Radspherin in phase 2 ovarian cancer trial

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026